SignalChem 2019-nCoV High Sensitivity S1 Protein ELISA Kit
The spread of the Severe Acute Respiratory Syndrome-related novel coronavirus SARS-CoV-2 led to the global pandemic of the respiratory disease (COVID-19) in 2020. Researchers across the globe are working to develop potential treatments, vaccines and drugs to combat the new coronavirus and 2019-nCoV acute respiratory disease.
RT-PCR is the earliest method that can be applied in the detection of pathogens, and a real-time fluorescent RT-PCR positive result is widely utilized as a means of confirming coronavirus infection.
Diagnosis via nucleic acid detection is prone to a number of problems such as false negatives, long detection times and strict requirements in terms of equipment and lab personnel expertise. Additional CT scans and other clinical symptom indicators are often required for an accurate diagnosis of COVID-19.